{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:30:28Z","timestamp":1789831828931,"version":"4.0.1"},"reference-count":67,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,1,23]]},"DOI":"10.1253\/circj.cj-25-0246","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T18:08:07Z","timestamp":1748628487000},"page":"152-161","source":"Crossref","is-referenced-by-count":8,"title":["Chronic Active Myocarditis and Inflammatory Cardiomyopathy\u3000\u2015 Challenges in Diagnosis and Treatment \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Toshiyuki","family":"Nagai","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Katsuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Beppu Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisaki","family":"Amemiya","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Oyama-Manabe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jichi Medical University Saitama Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ohta-Ogo","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Imanaka-Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine"},{"name":"Mie University Onco-Cardiology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"},{"name":"Department of Diagnostic Pathology, Hokusetsu General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Japanese Circulation Society. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): Digest version. <i>Circ J<\/i> 2011; 75: 734\u2013743.","DOI":"10.1253\/circj.CJ-88-0008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Aretz HT. Myocarditis: The Dallas criteria. <i>Hum Pathol<\/i> 1987; 18: 619\u2013624.","DOI":"10.1016\/S0046-8177(87)80363-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Seferovi\u0107 PM, Tsutsui H, McNamara DM, Risti\u0107 AD, Basso C, Bozkurt B, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. <i>Eur J Heart Fail<\/i> 2021; 23: 854\u2013871.","DOI":"10.1002\/ejhf.2190"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. <i>Eur Heart J<\/i> 2013; 34: 2636\u20132648, 2648a\u20132648d.","DOI":"10.1093\/eurheartj\/eht210"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: An Expert Consensus Document. <i>Circ Heart Fail<\/i> 2020; 13: e007405.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lauer B, Niederau C, K\u00fchl U, Schannwell M, Pauschinger M, Strauer BE, et al. Cardiac troponin T in patients with clinically suspected myocarditis. <i>J Am Coll Cardiol<\/i> 1997; 30: 1354\u20131359.","DOI":"10.1016\/S0735-1097(97)00317-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ukena C, Kindermann M, Mahfoud F, Geisel J, Lepper PM, Kandolf R, et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. <i>Clin Res Cardiol<\/i> 2014; 103: 743\u2013751.","DOI":"10.1007\/s00392-014-0709-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis: Experimental and clinical correlates. <i>Circulation<\/i> 1997; 95: 163\u2013168.","DOI":"10.1161\/01.CIR.95.1.163"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations. <i>J Am Coll Cardiol<\/i> 2018; 72: 3158\u20133176.","DOI":"10.1016\/j.jacc.2018.09.072"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kotanidis CP, Bazmpani MA, Haidich AB, Karvounis C, Antoniades C, Karamitsos TD. Diagnostic accuracy of cardiovascular magnetic resonance in acute myocarditis: A systematic review and meta-analysis. <i>JACC Cardiovasc Imaging<\/i> 2018; 11: 1583\u20131590.","DOI":"10.1016\/j.jcmg.2017.12.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagai T, Inomata T, Kohno T, Sato T, Tada A, Kubo T, et al. JCS 2023 Guideline on the diagnosis and treatment of myocarditis. <i>Circ J<\/i> 2023; 87: 674\u2013754.","DOI":"10.1253\/circj.CJ-22-0696"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tsch\u00f6pe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. <i>Nat Rev Cardiol<\/i> 2021; 18: 169\u2013193.","DOI":"10.1038\/s41569-020-00435-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Basso C. Myocarditis. <i>N Engl J Med<\/i> 2022; 387: 1488\u20131500.","DOI":"10.1056\/NEJMra2114478"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Omori T, Maruyama K, Ohta-Ogo K, Hatakeyama K, Ishibashi-Ueda H, Onoue K, et al. Clinical and histopathological characteristics of patients with myocarditis after mRNA COVID-19 vaccination. <i>Circ J<\/i> 2024; 89: 120\u2013129.","DOI":"10.1253\/circj.CJ-24-0506"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, et al. 2011 Consensus Statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. <i>Cardiovasc Pathol<\/i> 2012; 21: 245\u2013274.","DOI":"10.1016\/j.carpath.2011.10.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Basso C, Calabrese F, Angelini A, Carturan E, Thiene G. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. <i>Heart Fail Rev<\/i> 2013; 18: 673\u2013681.","DOI":"10.1007\/s10741-012-9355-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imanaka-Yoshida K. Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy. <i>Pathol Int<\/i> 2020; 70: 1\u201311.","DOI":"10.1111\/pin.12868"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Heymans S, Lakdawala NK, Tsch\u00f6pe C, Klingel K. Dilated cardiomyopathy: Causes, mechanisms, and current and future treatment approaches. <i>Lancet<\/i> 2023; 402: 998\u20131011.","DOI":"10.1016\/S0140-6736(23)01241-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ohta-Ogo K, Sugano Y, Ogata S, Nakayama T, Komori T, Eguchi K, et al. Myocardial T-lymphocytes as a prognostic risk-stratifying marker of dilated cardiomyopathy: Results of the Multicenter Registry to Investigate Inflammatory Cell Infiltration in Dilated Cardiomyopathy in Tissues of Endomyocardial Biopsy (INDICATE Study). <i>Circ J<\/i> 2022; 86: 1092\u20131101.","DOI":"10.1253\/circj.CJ-21-0529"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. <i>Lancet<\/i> 2017; 390: 400\u2013414.","DOI":"10.1016\/S0140-6736(16)31713-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. <i>Circ Res<\/i> 2017; 121: 803\u2013818.","DOI":"10.1161\/CIRCRESAHA.117.310221"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, et al. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. <i>J Biol Chem<\/i> 2010; 285: 23208\u201323223.","DOI":"10.1074\/jbc.M109.047464"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lv H, Havari E, Pinto S, Gottumukkala RV, Cornivelli L, Raddassi K, et al. Impaired thymic tolerance to \u03b1-myosin directs autoimmunity to the heart in mice and humans. <i>J Clin Invest<\/i> 2011; 121: 1561\u20131573.","DOI":"10.1172\/JCI44583"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. <i>Eur J Heart Fail<\/i> 2002; 4: 411\u2013417.","DOI":"10.1016\/S1388-9842(02)00010-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bracamonte-Baran W, \u010cih\u00e1kov\u00e1 D. Cardiac autoimmunity: Myocarditis. <i>Adv Exp Med Biol<\/i> 2017;  1003: 187\u2013221.","DOI":"10.1007\/978-3-319-57613-8_10"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Savvatis K, M\u00fcller I, Fr\u00f6hlich M, Pappritz K, Zietsch C, Hamdani N, et al. Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis. <i>Basic Res Cardiol<\/i> 2014; 109: 449.","DOI":"10.1007\/s00395-014-0449-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future. <i>Circulation<\/i> 1999; 99: 1091\u20131100.","DOI":"10.1161\/01.CIR.99.8.1091"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Humeres C, Vivar R, Boza P, Mu\u00f1oz C, Bolivar S, Anfossi R, et al. Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1\/M2 balance in vitro. <i>J Mol Cell Cardiol<\/i> 2016; 101: 30\u201340.","DOI":"10.1016\/j.yjmcc.2016.10.014"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Peng J, Gurantz D, Tran V, Cowling RT, Greenberg BH. Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. <i>Circ Res<\/i> 2002; 91: 1119\u20131126.","DOI":"10.1161\/01.RES.0000047090.08299.D5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sullivan DE, Ferris M, Nguyen H, Abboud E, Brody AR. TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. <i>J Cell Mol Med<\/i> 2009; 13: 1866\u20131876.","DOI":"10.1111\/j.1582-4934.2009.00647.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Condorelli G, Morisco C, Latronico MV, Claudio PP, Dent P, Tsichlis P, et al. TNF-alpha signal transduction in rat neonatal cardiac myocytes: Definition of pathways generating from the TNF-alpha receptor. <i>FASEB J<\/i> 2002; 16: 1732\u20131737.","DOI":"10.1096\/fj.02-0419com"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Takahashi M. NLRP3 inflammasome as a novel player in myocardial infarction. <i>Int Heart J<\/i> 2014; 55: 101\u2013105.","DOI":"10.1536\/ihj.13-388"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Chandrasekar B, Vemula K, Surabhi RM, Li-Weber M, Owen-Schaub LB, Jensen LE, et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. <i>J Biol Chem<\/i> 2004; 279: 20221\u201320233.","DOI":"10.1074\/jbc.M313980200"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Woodfin A, Voisin MB, Imhof BA, Dejana E, Engelhardt B, Nourshargh S. Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. <i>Blood<\/i> 2009; 113: 6246\u20136257.","DOI":"10.1182\/blood-2008-11-188375"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Tamaru M, Tomura K, Sakamoto S, Tezuka K, Tamatani T, Narumi S. Interleukin-1beta induces tissue- and cell type-specific expression of adhesion molecules in vivo. <i>Arterioscler Thromb Vasc Biol<\/i> 1998; 18: 1292\u20131303.","DOI":"10.1161\/01.ATV.18.8.1292"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nakayama T, Ogo KO, Sugano Y, Yokokawa T, Kanamori H, Ikeda Y, et al. Clinical impact of combined assessment of myocardial inflammation and fibrosis using myocardial biopsy in patients with dilated cardiomyopathy: A multicentre, retrospective cohort study. <i>Open Heart<\/i> 2025; 12: e003250.","DOI":"10.1136\/openhrt-2025-003250"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Baughman KL. Diagnosis of myocarditis: Death of Dallas criteria. <i>Circulation<\/i> 2006; 113: 593\u2013595.","DOI":"10.1161\/CIRCULATIONAHA.105.589663"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kindermann I, Kindermann M, Kandolf R, Klingel K, B\u00fcltmann B, M\u00fcller T, et al. Predictors of outcome in patients with suspected myocarditis. <i>Circulation<\/i> 2008; 118: 639\u2013648.","DOI":"10.1161\/CIRCULATIONAHA.108.769489"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. De Gaspari M, Larsen BT, d\u2019Amati G, Kreutz K, Basso C, Michaud K, et al. Diagnosing myocarditis in endomyocardial biopsies: Survey of current practice. <i>Cardiovasc Pathol<\/i> 2023; 64: 107494.","DOI":"10.1016\/j.carpath.2022.107494"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Kobayashi Y, Hamaya T, Nagai T, Mori Y, Sato T, Tsuneta S, et al. Multimodal assessment of immunosuppressive therapy in a patient with chronic active myocarditis 3 months following COVID-19 infection. <i>CJC Open<\/i> 2024; 6: 826\u2013829.","DOI":"10.1016\/j.cjco.2024.03.010"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, et al. Involvement of large tenascin-C splice variants in breast cancer progression. <i>Am J Pathol<\/i> 2003; 162: 1857\u20131867.","DOI":"10.1016\/S0002-9440(10)64320-9"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Lurz P, Luecke C, Eitel I, F\u00f6hrenbach F, Frank C, Grothoff M, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: The MyoRacer-Trial. <i>J Am Coll Cardiol<\/i> 2016; 67: 1800\u20131811.","DOI":"10.1016\/j.jacc.2016.02.013"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Lurz P, Eitel I, Adam J, Steiner J, Grothoff M, Desch S, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. <i>JACC Cardiovasc Imaging<\/i> 2012; 5: 513\u2013524.","DOI":"10.1016\/j.jcmg.2011.11.022"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kobayashi Y, Nagai T, Kamiya K, Tsuneta S, Shingu Y, Wakabayashi K, et al. Chronic active myocarditis after transapical transcatheter aortic valve implantation. <i>Circ J<\/i> 2024; 88: 1008.","DOI":"10.1253\/circj.CJ-23-0910"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Radunski UK, Lund GK, Stehning C, Schnackenburg B, Bohnen S, Adam G, et al. CMR in patients with severe myocarditis: Diagnostic value of quantitative tissue markers including extracellular volume imaging. <i>JACC Cardiovasc Imaging<\/i> 2014; 7: 667\u2013675.","DOI":"10.1016\/j.jcmg.2014.02.005"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. <i>Eur Heart J<\/i> 2021; 42: 3599\u20133726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. <i>Eur J Heart Fail<\/i> 2024; 26: 5\u201317.","DOI":"10.1002\/ejhf.3024"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, et al.; on behalf of the Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS\/JHFS 2025 Guideline on diagnosis and treatment of heart failure. <i>Circ J<\/i> 2025; 89: 1278\u20131444, doi:10.1253\/circj.CJ-25-0002.","DOI":"10.1253\/circj.CJ-25-0002"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Yoshioka G, Tanaka A, Sonoda S, Kaneko T, Hongo H, Yokoi K, et al. Importance of reassessment to identify trajectories of chronic transition of clinical indicators in post-myocardial infarction management. <i>Cardiovasc Interv Ther<\/i> 2024; 39: 234\u2013240.","DOI":"10.1007\/s12928-024-01000-w"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Kario K, Kai H, Rakugi H, Hoshide S, Node K, Maekawa Y, et al. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS). <i>Cardiovasc Interv Ther<\/i> 2024; 39: 376\u2013385.","DOI":"10.1007\/s12928-024-01017-1"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Miyawaki N, Takashima A. Evidence of cardiac rehabilitation for heart failure with reduced ejection fraction in recovery to maintenance phase. <i>Circ Rep<\/i> 2025; 7: 4\u20135.","DOI":"10.1253\/circrep.CR-24-0134"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Tara S, Yamamoto T, Kanaoka K, Oka E, Shiomura R, Matsuda J, et al. Effects of cardioprotective drugs on 90-day mortality or heart transplantation in patients with fulminant myocarditis. <i>Circ Rep<\/i> 2024; 6: 322\u2013332.","DOI":"10.1253\/circrep.CR-24-0059"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. <i>N Engl J Med<\/i> 1989; 321: 1061\u20131068.","DOI":"10.1056\/NEJM198910193211601"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results. <i>Circulation<\/i> 2001; 104: 39\u201345.","DOI":"10.1161\/01.CIR.104.1.39"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. <i>Circulation<\/i> 2003; 107: 857\u2013863.","DOI":"10.1161\/01.CIR.0000048147.15962.31"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: The TIMIC study. <i>Eur Heart J<\/i> 2009; 30: 1995\u20132002.","DOI":"10.1093\/eurheartj\/ehp249"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Merken J, Hazebroek M, Van Paassen P, Verdonschot J, Van Empel V, Knackstedt C, et al. Immunosuppressive therapy improves both short- and long-term prognosis in patients with virus-negative nonfulminant inflammatory cardiomyopathy. <i>Circ Heart Fail<\/i> 2018; 11: e004228.","DOI":"10.1161\/CIRCHEARTFAILURE.117.004228"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Chimenti C, Russo MA, Frustaci A. Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial. <i>Eur Heart J<\/i> 2022; 43: 3463\u20133473.","DOI":"10.1093\/eurheartj\/ehac348"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Caforio ALP, Giordani AS, Baritussio A, Marcolongo D, Vicenzetto C, Tarantini G, et al. Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: A propensity-weighted study. <i>Eur J Heart Fail<\/i> 2024; 26: 1175\u20131185.","DOI":"10.1002\/ejhf.3220"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Mason JW, O\u2019Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis: The Myocarditis Treatment Trial Investigators. <i>N Engl J Med<\/i> 1995; 333: 269\u2013275.","DOI":"10.1056\/NEJM199508033330501"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Bock CT, Klingel K, Kandolf R. Human parvovirus B19-associated myocarditis. <i>N Engl J Med<\/i> 2010; 362: 1248\u20131249.","DOI":"10.1056\/NEJMc0911362"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Tsch\u00f6pe C, Elsanhoury A, Schlieker S, Van Linthout S, K\u00fchl U. Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence. <i>Eur J Heart Fail<\/i> 2019; 21: 1468\u20131469.","DOI":"10.1002\/ejhf.1560"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Elsanhoury A, K\u00fchl U, Stautner B, Klein O, Krannich A, Morris D, et al. The spontaneous course of human herpesvirus 6 DNA-associated myocarditis and the effect of immunosuppressive intervention. <i>Viruses<\/i> 2022; 14: 299.","DOI":"10.3390\/v14020299"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Sinagra G, Porcari A, Gentile P, Artico J, Fabris E, Bussani R, et al. Viral presence-guided immunomodulation in lymphocytic myocarditis: An update. <i>Eur J Heart Fail<\/i> 2021; 23: 211\u2013216.","DOI":"10.1002\/ejhf.1969"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Tsch\u00f6pe C, Cooper LT, Torre-Amione G, Van Linthout S. Management of myocarditis-related cardiomyopathy in adults. <i>Circ Res<\/i> 2019; 124: 1568\u20131583.","DOI":"10.1161\/CIRCRESAHA.118.313578"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Felix SB, Staudt A, D\u00f6rffel WV, Stangl V, Merkel K, Pohl M, et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: Three-month results from a randomized study. <i>J Am Coll Cardiol<\/i> 2000; 35: 1590\u20131598.","DOI":"10.1016\/S0735-1097(00)00568-4"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Heymans S, Van Linthout S, Kraus SM, Cooper LT, Ntusi NAB. Clinical characteristics and mechanisms of acute myocarditis. <i>Circ Res<\/i> 2024; 135: 397\u2013411.","DOI":"10.1161\/CIRCRESAHA.124.324674"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/2\/90_CJ-25-0246\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:19:11Z","timestamp":1769224751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/2\/90_CJ-25-0246\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0246","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"CJ-25-0246"}}